13,698 Shares in Pediatrix Medical Group, Inc. (NYSE:MD) Bought by AXQ Capital LP

AXQ Capital LP purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 13,698 shares of the company’s stock, valued at approximately $180,000.

Several other large investors have also recently modified their holdings of MD. State Street Corp boosted its holdings in Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after acquiring an additional 50,597 shares in the last quarter. Nordea Investment Management AB lifted its stake in shares of Pediatrix Medical Group by 51.6% in the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock worth $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC boosted its stake in shares of Pediatrix Medical Group by 302.9% during the 3rd quarter. Barclays PLC now owns 142,087 shares of the company’s stock worth $1,646,000 after acquiring an additional 106,817 shares during the last quarter. Franklin Resources Inc. purchased a new stake in Pediatrix Medical Group in the third quarter worth about $598,000. Finally, Principal Financial Group Inc. increased its holdings in Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after acquiring an additional 63,581 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $14.51 on Tuesday. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The firm has a market cap of $1.25 billion, a PE ratio of -12.09, a P/E/G ratio of 1.74 and a beta of 1.49. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The business has a 50-day moving average price of $14.33 and a 200 day moving average price of $13.58.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on MD shares. UBS Group boosted their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Macquarie started coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. Finally, Truist Financial raised their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.